Key takeaways
Breo Ellipta (fluticasone furoate / vilanterol) and Symbicort (budesonide / formoterol) are both inhaled medications used to treat asthma and chronic obstructive pulmonary disease (COPD). They belong to the same drug class, combining an inhaled corticosteroid with a long-acting beta agonist (LABA). However, they differ in several ways. Breo Ellipta is typically taken once a day, while Symbicort is taken twice a day. Breo Ellipta is available in three strengths and is safe for children 5 years and older for asthma, whereas Symbicort comes in two strengths and is safe for children 6 years and older. Breo Ellipta has a generic version available, while Symbicort's generic is called Breyna. Common side effects for both include oral thrush and headache, while Symbicort may cause sinus infections. Both medications can interact with other LABAs, increasing the risk of overdose.
Prices with our coupons for Breo Ellipta vs. Symbicort
